Pink Sheet Podcast: Amylyx’s Adcom Success, Trials Leave Russia, Apolitical Drug Price Negotiations

Citeline Podcasts

English - September 09, 2022 16:54 - 42 minutes - 26.6 MB - ★★★★★ - 24 ratings
Business News Business News Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Getting Personal With De Oro Devices’ Sidney Collin:‘There’s A Lot Of Learning That Needs To Happen’

Next Episode: Medtech Monthly: Breakthrough Device Analysis with Bradley Merrill Thompson

Pink Sheet reporters and editors discuss the positive advisory committee recommendation for Amylyx’s proposed ALS treatment, the striking drop in clinical trials conducted in Russia following the start of the war in Ukraine, and questions about Medicare price negotiations avoiding political influence.